Literature DB >> 7880789

Comparison of colour discrimination and electroretinography in evaluation of visual pathway dysfunction in aretinopathic IDDM patients.

K J Hardy1, C Fisher, P Heath, D H Foster, J H Scarpello.   

Abstract

The slow progression of diabetic retinopathy makes it difficult to assess the effects of intervention therapy. There is thus a need for surrogate markers of visual change in diabetes. Colour vision tests and electroretinography (ERG) may be useful in this regard; yet little is known of their relative performance in the assessment of visual dysfunction in diabetes. The aim of the present study was to compare colour discrimination (100 hue test) and ERG indices (oscillatory potentials (OP) and pattern ERG (PERG)) in the evaluation of aretinopathic IDDM patients. Colour discrimination was abnormal in 10 aretinopathic IDDM patients when compared with nine age matched controls; mean square root 100 hue error scores were 10.38 (SD 2.89) versus 4.77 (1.87) respectively, p < 0.01. OP implicit times of the ERG were also abnormal; for example, for right eye, mean OP1 implicit time for diabetics versus OP1 implicit time for controls was 20.1 (2.0) versus 18.6 (1.4) ms, p = 0.03. Comparison of the two techniques suggested that the 100 hue test was more sensitive and more specific than ERG OP implicit times in the detection of diabetic visual dysfunction in these patients.

Entities:  

Mesh:

Year:  1995        PMID: 7880789      PMCID: PMC505015          DOI: 10.1136/bjo.79.1.35

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Further studies on acquired deficiency of color discrimination.

Authors:  G VERRIEST
Journal:  J Opt Soc Am       Date:  1963-01

2.  Proposals for scoring and assessing the 100-Hue test.

Authors:  P R Kinnear
Journal:  Vision Res       Date:  1970-05       Impact factor: 1.886

3.  The electroretinogram in minimal diabetic retinopathy.

Authors:  T C Jenkins; J P Cartwright
Journal:  Br J Ophthalmol       Date:  1990-11       Impact factor: 4.638

4.  A new assessment of the normal ranges of the Farnsworth-Munsell 100-hue test scores.

Authors:  G Verriest; J Van Laethem; A Uvijls
Journal:  Am J Ophthalmol       Date:  1982-05       Impact factor: 5.258

5.  Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report.

Authors:  G H Bresnick; K Korth; A Groo; M Palta
Journal:  Arch Ophthalmol       Date:  1984-09

6.  Temporal aspects of the electroretinogram in diabetic retinopathy.

Authors:  G H Bresnick; M Palta
Journal:  Arch Ophthalmol       Date:  1987-05

7.  Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas.

Authors:  K J Hardy; J Lipton; M O Scase; D H Foster; J H Scarpello
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

8.  A comparison of oscillatory potential and pattern electroretinogram measures in diabetic retinopathy.

Authors:  S G Coupland
Journal:  Doc Ophthalmol       Date:  1987-06       Impact factor: 2.379

9.  Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study.

Authors:  O Brinchmann-Hansen; K Dahl-Jørgensen; L Sandvik; K F Hanssen
Journal:  BMJ       Date:  1992-01-04

10.  Color vision defects in early diabetic retinopathy.

Authors:  M S Roy; R D Gunkel; M J Podgor
Journal:  Arch Ophthalmol       Date:  1986-02
  10 in total
  10 in total

Review 1.  A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Authors:  Marcus A Bearse; Anthony J Adams; Ying Han; Marilyn E Schneck; Jason Ng; Kevin Bronson-Castain; Shirin Barez
Journal:  Prog Retin Eye Res       Date:  2006-09-01       Impact factor: 21.198

Review 2.  Psychophysical Exams as Early Indicators of Diabetic Retinopathy.

Authors:  Nicola Pescosolido; Giuseppe Buomprisco
Journal:  Eur Endocrinol       Date:  2014-02-28

3.  Impaired saccadic eye movement in diabetic patients: the relationship with visual pathways function.

Authors:  M Alessandrini; V Paris; E Bruno; P G Giacomini
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

4.  Color vision and neuroretinal function in diabetes.

Authors:  B E Wolff; M A Bearse; M E Schneck; K Dhamdhere; W W Harrison; S Barez; A J Adams
Journal:  Doc Ophthalmol       Date:  2014-12-17       Impact factor: 2.379

5.  Extent of foveal tritanopia in diabetes mellitus.

Authors:  N Davies; A Morland
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

6.  Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina.

Authors:  S-H Park; J-W Park; S-J Park; K-Y Kim; J-W Chung; M-H Chun; S-J Oh
Journal:  Diabetologia       Date:  2003-07-31       Impact factor: 10.122

7.  Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease.

Authors:  Ivy S Samuels; Chieh-Allen Lee; J Mark Petrash; Neal S Peachey; Timothy S Kern
Journal:  Vis Neurosci       Date:  2012-10-29       Impact factor: 3.241

Review 8.  Photoreceptor cells and RPE contribute to the development of diabetic retinopathy.

Authors:  Deoye Tonade; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2020-11-12       Impact factor: 19.704

9.  Investigation of the Protective Effects of Taurine against Alloxan-Induced Diabetic Retinal Changes via Electroretinogram and Retinal Histology with New Zealand White Rabbits.

Authors:  Samuel Tung-Hsing Chiang; Shang-Min Yeh; Yi-Chen Chen; Shiun-Long Lin; Jung-Kai Tseng
Journal:  Int J Endocrinol       Date:  2014-09-14       Impact factor: 3.257

10.  Retinal adaptation to changing glycemic levels in a rat model of type 2 diabetes.

Authors:  Leif E Johnson; Michael Larsen; Maria-Thereza Perez
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.